These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 34100993)

  • 1. Second-generation antipsychotic use during pregnancy and risk of congenital malformations.
    Ellfolk M; Leinonen MK; Gissler M; Kiuru-Kuhlefelt S; Saastamoinen L; Malm H
    Eur J Clin Pharmacol; 2021 Nov; 77(11):1737-1745. PubMed ID: 34100993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second-generation antipsychotics and pregnancy complications.
    Ellfolk M; Leinonen MK; Gissler M; Lahesmaa-Korpinen AM; Saastamoinen L; Nurminen ML; Malm H
    Eur J Clin Pharmacol; 2020 Jan; 76(1):107-115. PubMed ID: 31680189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of In Utero Antipsychotic Medication Exposure With Risk of Congenital Malformations in Nordic Countries and the US.
    Huybrechts KF; Straub L; Karlsson P; Pazzagli L; Furu K; Gissler M; Hernandez-Diaz S; Nørgaard M; Zoega H; Bateman BT; Cesta CE; Cohen JM; Leinonen MK; Reutfors J; Selmer RM; Suarez EA; Ulrichsen SP; Kieler H
    JAMA Psychiatry; 2023 Feb; 80(2):156-166. PubMed ID: 36477338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Major Congenital Malformations Associated With Exposure to Second-Generation Antipsychotic Drugs During Pregnancy.
    Andrade C
    J Clin Psychiatry; 2021 Oct; 82(5):. PubMed ID: 34610230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of congenital malformations associated with first-trimester exposure to antipsychotics: A propensity score-weighted population-based cohort study.
    Chan JKN; Lee KCK; Wong CSM; Chang WC
    Eur Psychiatry; 2024 May; 67(1):e42. PubMed ID: 38800849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal antipsychotic use during pregnancy and congenital malformations.
    Liu X; Kolding L; Momen N; Gasse C; Pedersen LH
    Am J Obstet Gynecol MFM; 2023 Jun; 5(6):100950. PubMed ID: 37015311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reproductive Safety of Second-Generation Antipsychotics: Current Data From the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics.
    Cohen LS; Viguera AC; McInerney KA; Freeman MP; Sosinsky AZ; Moustafa D; Marfurt SP; Kwiatkowski MA; Murphy SK; Farrell AM; Chitayat D; Hernández-Díaz S
    Am J Psychiatry; 2016 Mar; 173(3):263-70. PubMed ID: 26441156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exposure to duloxetine during pregnancy and risk of congenital malformations and stillbirth: A nationwide cohort study in Denmark and Sweden.
    Ankarfeldt MZ; Petersen J; Andersen JT; Li H; Motsko SP; Fast T; Hede SM; Jimenez-Solem E
    PLoS Med; 2021 Nov; 18(11):e1003851. PubMed ID: 34807906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations.
    Huybrechts KF; Hernández-Díaz S; Patorno E; Desai RJ; Mogun H; Dejene SZ; Cohen JM; Panchaud A; Cohen L; Bateman BT
    JAMA Psychiatry; 2016 Sep; 73(9):938-46. PubMed ID: 27540849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metoclopramide in pregnancy and risk of major congenital malformations and fetal death.
    Pasternak B; Svanström H; Mølgaard-Nielsen D; Melbye M; Hviid A
    JAMA; 2013 Oct; 310(15):1601-11. PubMed ID: 24129464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy Outcomes With Exposure to Second-Generation Antipsychotics During the First Trimester.
    Yakuwa N; Takahashi K; Anzai T; Ito N; Goto M; Koinuma S; Uno C; Suzuki T; Watanabe O; Yamatani A; Murashima A
    J Clin Psychiatry; 2022 Jun; 83(4):. PubMed ID: 35687862
    [No Abstract]   [Full Text] [Related]  

  • 12. Herbal medicines used during the first trimester and major congenital malformations: an analysis of data from a pregnancy cohort study.
    Chuang CH; Doyle P; Wang JD; Chang PJ; Lai JN; Chen PC
    Drug Saf; 2006; 29(6):537-48. PubMed ID: 16752935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry.
    Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Perucca E; Sabers A; Thomas SV; Vajda F;
    Lancet Neurol; 2018 Jun; 17(6):530-538. PubMed ID: 29680205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy exposure to olanzapine, quetiapine, risperidone, aripiprazole and risk of congenital malformations. A systematic review.
    Ennis ZN; Damkier P
    Basic Clin Pharmacol Toxicol; 2015 Apr; 116(4):315-20. PubMed ID: 25536446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study.
    McKenna K; Koren G; Tetelbaum M; Wilton L; Shakir S; Diav-Citrin O; Levinson A; Zipursky RB; Einarson A
    J Clin Psychiatry; 2005 Apr; 66(4):444-9; quiz 546. PubMed ID: 15816786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproductive Safety of Second-Generation Antipsychotics: Updated Data From the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics.
    Viguera AC; Freeman MP; Góez-Mogollón L; Sosinsky AZ; McElheny SA; Church TR; Young AV; Caplin PS; Chitayat D; Hernández-Díaz S; Cohen LS
    J Clin Psychiatry; 2021 Aug; 82(4):. PubMed ID: 34352165
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of antibiotics during pregnancy and the risk of major congenital malformations: a population based cohort study.
    Muanda FT; Sheehy O; Bérard A
    Br J Clin Pharmacol; 2017 Nov; 83(11):2557-2571. PubMed ID: 28722171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuraminidase inhibitors during pregnancy and risk of adverse neonatal outcomes and congenital malformations: population based European register study.
    Graner S; Svensson T; Beau AB; Damase-Michel C; Engeland A; Furu K; Hviid A; Håberg SE; Mølgaard-Nielsen D; Pasternak B; Kieler H
    BMJ; 2017 Feb; 356():j629. PubMed ID: 28246106
    [No Abstract]   [Full Text] [Related]  

  • 19. Topiramate use during pregnancy and major congenital malformations in multiple populations.
    Tennis P; Chan KA; Curkendall SM; Li DK; Mines D; Peterson C; Andrews EB; Calingaert B; Chen HY; Deshpande G; Everage N; Holick CN; Meyer NM; Nkhoma ET; Quinn S; Rothman KJ; Esposito DB
    Birth Defects Res A Clin Mol Teratol; 2015 Apr; 103(4):269-75. PubMed ID: 25776342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of Major Malformations Following First-Trimester Exposure to Olanzapine: Preliminary Data From the Massachusetts General Hospital National Pregnancy Registry for Psychiatric Medications.
    Viguera AC; Freeman MP; Kobylski LA; Rossa ET; Gaccione P; Chitayat D; Hernández-Díaz S; Cohen LS
    J Clin Psychopharmacol; 2023 Mar-Apr 01; 43(2):106-112. PubMed ID: 36825887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.